Background Studies regarding the impact of Parkinson's disease (PD) on quality of life
(QOL) have reported conflicting results, and the underlying QOL domains require further …

Purpose New patient reported outcome (PRO) measures are regularly developed to assess
various aspects of the patients' perspective on their disease and treatment. For these …

Background Subthalamic stimulation reduces motor disability and improves quality of life in
patients with advanced Parkinson's disease who have severe levodopa-induced motor …

Nonmotor symptoms (NMS) are common in patients with established Parkinson's disease
(PD) and have a major impact upon quality of life. We investigated the significance of NMS …

Objective Real‐life observational report of clinical efficacy of bilateral subthalamic
stimulation (STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on …

Introduction Parkinson's disease dementia (PDD) is associated with poorer quality of life
(QoL). Prior to the onset of PDD, many patients experience progressive cognitive …

Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for
patients with advanced Parkinson's disease improving quality of life, motor symptoms and …

We analyzed features associated with a reduction in Health-Related Quality of Life (HRQoL)
in people with idiopathic Parkinson's disease (PD). As a new approach, features were …

Background Quality of life in Parkinson's disease (PD) is affected by motor and nonmotor
symptoms, necessitating an integrated care approach. Existing care models vary …

Background The relative impact of motor-and non-motor symptoms on health-related quality
of life in early Parkinson's disease is poorly documented. Methods 188 patients with incident …